ArticleInternational journal of molecular sciences2021

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.

Renée Poels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.